ERBB2 and breast cancer: The subtyping of breast cancer, traditionally based on classic IHC markers (ER, PR, and HER2) and pathological variables (tumor size, tumor grade, and nodal involvement) [70], is now enriched through insights from MDSP into tumor heterogeneity [71].